AMES, Iowa, Nov. 1, 2007 (PRIME NEWSWIRE) -- BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH) announced today that the Company's President and Chief Operating Officer, Kerry Frey, will present at the Rodman & Renshaw 9th Annual Healthcare Conference on Wednesday, Nov. 7, 2007 at 1:20 p.m. EST at the New York Plaza Hotel, 455 Madison Avenue, New York, N.Y.
Mr. Frey's presentation will discuss the Company's progress in marketing its Nano eNabler(tm) molecular printer to research institutions, as well as BioForce's utilization of the Nano eNabler(tm) to develop its ViriChip(tm) pathogen detection system and its NanoDiagnostics group of miniaturized diagnostic tests.
A live webcast of the presentation will be available via BioForce's website at www.bioforcenano.com and will be archived for 90 days following the presentation.
About BioForce Nanosciences Holdings, Inc.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. BioForce's flagship product, the Nano eNabler(tm) molecular printer, gives the Company a platform for development and discovery. BioForce technology is being used in sensor functionalization, patterning and cell adhesion, and printing proteins to guide neural cell growth. For more information, visit www.bioforcenano.com or call 515-233-8333.
This news release contains forward-looking information that may be affected by certain risks and uncertainties, including those risks and uncertainties described in BioForce Nanosciences' most recent filings with the Securities and Exchange Commission. BioForce Nanosciences' actual results could differ materially from such forward-looking statements. BioForce assumes no duty to update these statements at any future date.